36MO Location and size of metastasectomy in melanoma patients treated with tumor-infiltrating lymphocytes (TIL) in relation to clinical outcome
Maartje W. Rohaan, T. Holz Borch, R. Kessels, C. Nijenhuis et autres
Development of novel treatment options is essential for patients with metastatic melanoma (MM), as about half derive no durable benefit upon first-line treatment. Adoptive cell therapy with TIL has shown encouraging results in a recently completed multicenter phase 3 trial evaluating TIL …
nl, dk (code pays fourni par la source)